Jointly explore innovative medical insurance services to provide customers with diverse and high-quality healthcare options

AXA China Region Insurance Company (Bermuda) Limited ("AXA") formally signed an official cooperation agreement with Hainan Boao Lecheng International Medical Tourism Pilot Zone Administration ("Lecheng Administration"). The partnership aims jointly explore more innovative medical insurance models and leverage the top-tier medical resources of Hainan Boao Lecheng to provide customers with more high-quality cross-border medical options.

The Hainan Boao Lecheng International Medical Tourism Pilot Zone ("the Pilot Zone") was approved by the State Council¹ in 2013 as the only medical special zone in China, enjoying preferential policies covering licensed medical services, operations, research, and international exchanges. Since approval, the Pilot Zone has attracted leading medical institutions and specialist teams, introducing advanced international treatment protocols, innovative pharmaceuticals, and medical devices into China for trial use – including therapies for rare diseases and cutting-edge cancer treatments. Meanwhile, AXA has partnered with China Biotech Services Holdings Limited (HKEX stock code: 8037; "China Biotech Services") to explore Boron Neutron Capture Therapy ("BNCT"), a pioneering initiative now being established within the Pilot Zone.